Key result
Pulmonary vascular medicine has developed into a distinct, specialized discipline in China over the past 40 years, driven by advances in research, standardized treatments, and international collaboration.
This historical perspective highlights the evolution, key milestones, and future directions of pulmonary vascular medicine as a distinct medical specialty in China.
Answers are grounded in this paper and cite their sources.
Highlights progress in Chinese pulmonary vascular medicine; leaves open optimal global training and standardization models.
Over the past 40 years, Chinese experts have made great progress on research, diagnosis, and therapy of pulmonary vascular disease, including pulmonary embolism and pulmonary hypertension. These theoretical and clinical advances have increased public awareness about this group of conditions, which are associated with significant morbidity and mortality in China and worldwide. With its theoretical basis combining knowledge from cardiovascular and pulmonary medicine, pulmonary vascular disease has developed into a separate, unique specialty in hospitals across China and worldwide. This article will provide a short historical perspective but also an outlook into the future of this exciting novel discipline. We provide a Chinese perspective, based on our research and clinic experience over the past decades.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2012) conducted a review in Pulmonary vascular disease. Pulmonary vascular medicine has developed into a distinct, specialized discipline in China over the past 40 years, driven by advances in research, standardized treatments, and international collaboration.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: